Compare FSCO & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FSCO | AVNS |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2013 | 2014 |
| Metric | FSCO | AVNS |
|---|---|---|
| Price | $4.85 | $24.93 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 903.6K |
| Earning Date | 05-08-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.59 |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $701,200,000.00 |
| Revenue This Year | N/A | $3.28 |
| Revenue Next Year | N/A | $4.23 |
| P/E Ratio | ★ N/A | $226.73 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $4.28 | $9.30 |
| 52 Week High | $7.65 | $25.49 |
| Indicator | FSCO | AVNS |
|---|---|---|
| Relative Strength Index (RSI) | 45.01 | 58.71 |
| Support Level | $4.68 | $24.87 |
| Resistance Level | $5.06 | $25.49 |
| Average True Range (ATR) | 0.10 | 0.08 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 46.27 | 86.79 |
FS Credit Opportunities Corp is a closed-end management investment company. The Fund's primary investment objective is to generate an attractive total return consisting of a high level of current income and capital appreciation, with a secondary objective of capital preservation. It predominantly invests in a portfolio of secured and unsecured floating and fixed-rate loans, bonds, and other types of credit instruments. The credit instruments in which it invests are typically rated below investment grade by rating agencies or would be rated below investment grade if rated. To achieve its investment objectives, the fund focuses on strategies such as Opportunistic Credit, Special Situations, and Capital Structure Solutions.
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.